ReviewBioengineering & translational medicine2026
Engineered platforms for melanogenesis research: Bridging synthetic biology, bioengineering, and biomimetics.
Review in Bioengineering & translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanogenesis, the biological process responsible for melanin synthesis, plays a critical role in determining skin pigmentation and providing photoprotection. Dysregulation of this pathway leads to a wide range of pigmentary disorders that affect a significant proportion of the global population. Traditional approaches to studying melanogenesis rely largely on cultured melanocytes and in vivo animal models; however, these systems present several limitations, including concerns related to physiological relevance, ethical constraints, high maintenance costs, and limited scalability. In recent years, synthetic biology has emerged as a powerful framework for engineering controllable biological systems capable of replicating complex cellular pathways with high precision. Although numerous studies have reported individual synthetic biology approaches for pigment production or pathway engineering, the literature lacks a comprehensive synthesis that integrates these strategies within the broader context of melanogenesis research and its translational potential. This review addresses this gap by consolidating advances in synthetic biology platforms used to investigate and manipulate pigmentation biology. We discuss emerging techniques including genetic engineering, heterologous expression systems, biomimetic constructs, and cell-free assays that enable the reconstruction and modulation of melanin synthesis pathways. These engineered systems allow the development of disease-specific and patient-derived pigmentation models, providing new opportunities for mechanistic studies and personalized therapeutic strategies. Conceptually, this review proposes a unified framework that positions synthetic biology as a versatile toolkit for studying melanogenesis while also enabling scalable production of melanin and melanin-based biomaterials. By bridging developments across molecular engineering, microbial biosystems, and biomimetic technologies, this work highlights how non-conventional systems can transform both fundamental pigmentation research and translational applications in dermatology and biotechnology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.